Bellecapital’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-3,949
Closed -$217K 187
2022
Q2
$217K Hold
3,949
0.06% 186
2022
Q1
$298K Sell
3,949
-2,527
-39% -$173K 0.09% 155
2021
Q4
$483K Sell
6,476
-2,224
-26% -$132K 0.14% 119
2021
Q3
$409K Buy
+8,700
New +$378K 0.12% 139

Other funds holding ACLS

Bellecapital's ACLS Position: Q3 2022 in Review

Bellecapital sold out of Axcelis (ACLS) in Q3 2022, closing a stake of 3,949 shares — an estimated $217K sold.

Bellecapital first reported a position in ACLS in Q3 2021 and held it in 4 quarters. The position peaked at $483K in Q4 2021. 287 funds tracked by Wall St. Rank hold ACLS as of Q3 2022.

  • Bellecapital reported no remaining Axcelis position as of Q3 2022 after selling out during the quarter.
  • Bellecapital sold 3,949 Axcelis shares in Q3 2022, an estimated $217K.
  • Bellecapital first reported a position in Axcelis in Q3 2021 and held it in 4 quarters.
  • Bellecapital's Axcelis position peaked at $483K in Q4 2021.
  • 287 funds tracked by Wall St. Rank held Axcelis as of Q3 2022.

Based on Bellecapital's 13F filing for Q3 2022, filed 7 Nov 2022.